The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / A Public Health Approach to Arthritis

A Public Health Approach to Arthritis

March 12, 2020 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Helmick

Dr. Helmick

Although arthritis and rheumatism are more common among people older than 65, more people who are younger than 65 actually have arthritis, so the condition has big effects on work. According to the National Health Interview Survey, the most common causes of work disability are back or neck problems, which account for 30%; depression and anxiety, accounting for 21%; and arthritis and rheumatism, accounting for 19%. Making matters worse, arthritis is frequently seen alongside other chronic conditions: From 2013–15, the survey found 49% of those with heart disease also had arthritis, as did 47% of diabetes patients and 31% of obese people.

You Might Also Like
  • A Public Health Approach to Arthritis: Experts Continue to Raise Awareness of Arthritis Burden
  • U.S. Public Health Funding on the Decline
  • Straightforward Approach Can Help Rheumatology Health Professionals Engage with Fibromyalgia Patients
Explore This Issue
March 2020
Also By This Author
  • ACR Leaders Discuss E/M Coding Changes, Step Therapy & More

“In all three of these diseases, physical activity is the recommended management, so if you’re not being physically active, you’re not getting the proper management for your diseases,” Dr. Helmick said. “And the people who have these diseases plus arthritis are much less physically active than those who have the disease and don’t have arthritis. So arthritis is really a specific barrier to being physically active.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Researchers have also found that people with arthritis report 10 of the previous 30 days as “unhealthy” days, either physically or mentally, compared with 4.8 of the previous 30 for those without arthritis.5

Interventions from a public health perspective include not only physical activity, but education on how to self-manage, and research into prevention to strengthen the scientific basis for community interventions, Dr. Helmick said. Continued funding for state and national programs is needed to raise visibility and make inventions more available because people are more likely to participate in settings in the community than in typical clinical settings, he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Arthritis Awareness Campaigns

From 1999’s National Arthritis Action Plan to the National Public Health Agenda for Lupus: A Blueprint for Action in 2015 to its appearance in the CDC’s high-visibility Vital Signs reports and articles in the Morbidity and Mortality Weekly Report, arthritis awareness has been promoted by the CDC and other federal agencies.

Among other goals, the Healthy People 2020 campaign attempts to “attain high-quality, longer lives free of preventable disease, disability, injury and premature death.” The campaign includes several arthritis objectives, including the reduction of pain, activity limitations and employment issues. The 2030 campaign also includes objectives regarding arthritis.

Benefiting from Increased Attention to Pain Issues

Dr. Helmick also discussed how increased attention to generic pain issues and the opioid crisis may help raise the profile of arthritis as a public health threat. Such organizations as the Institute of Medicine, the U.S. Department of Health & Human Services and the White House have also made pain a primary focus, largely with the goal of reducing addiction to opioids. Pain reduction is a goal that is closely aligned with rheumatic disease treatment and awareness, Dr. Helmick said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The National Institutes of Health’s $945 million HEAL initiative—Helping to End Addiction Long-Term—will include money for research on pain signatures associated with the transition from acute to chronic pain, how to manage pain more effectively and optimizing non-addictive therapies to treat pain. With pain as an important outcome, “arthritis is positioned to take advantage,” he said.

“Arthritis and rheumatic conditions are major sources of chronic pain, so more general attention to pain, as has been happening over the past seven years—and pain as a major risk factor for prescribed opioids, which is a large part of the current opioid crisis—mean that arthritis and rheumatic conditions should be getting more attention from both the pain and opioid communities as part of their own agendas.”  

Pages: 1 2 3 | Single Page

Filed Under: 2019 ACR/ARP Annual Meeting, Analgesics, Conditions Tagged With: Centers for Disease Control and Prevention, opioid crisis, Pain Management, public healthIssue: March 2020

You Might Also Like:
  • A Public Health Approach to Arthritis: Experts Continue to Raise Awareness of Arthritis Burden
  • U.S. Public Health Funding on the Decline
  • Straightforward Approach Can Help Rheumatology Health Professionals Engage with Fibromyalgia Patients
  • Trump Declares Opioids a U.S. Public Health Emergency

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)